The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: Lessons learned from transgenic mice

Journal of Clinical Investigation

Volumn 104, Issue 8, 1999, Pages 1013-1014

  Searles, Charles D ^a   Harrison, David G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; BRADYKININ; NITRIC OXIDE;

CARDIOVASCULAR AUTOREGULATION; ENDOTHELIUM CELL; HEART FAILURE; HEART INFARCTION; KALLIKREIN KININ SYSTEM; MOUSE; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR ENDOTHELIUM;

EID: 0032696887     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8507     Document Type: Note

References (17)

1. Ichiki, T., et al. 1995. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 377:748-750.
2. Hein, L., Barsh, G.S., Pratt, R.E., Dzau, V.J., and Kobilka, B.K. 1995. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice [erratum 1996, 380:366]. Nature. 377:744-747.
3. Hutchinson, H.G., Hein, L., Fujinaga, M., and Pratt, R.E. 1999. Modulation of vascular development and injury by angiotensin II. Cardiovasc. Res. 41:689-700.
4. Nakajima, M., et al. 1995. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. USA. 92:10663-10667.
5. Liu, Y.H., et al. 1997. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J. Clin. Invest. 99:1926-1935.
6. Ohkubo, N., et al. 1997. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation. 96:3954-3962.
7. Nio, Y., Matsubara, H., Murasawa, S., Kanasaki, M., and Inada, M. 1995. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J. Clin. Invest. 95:46-54.
8. de Gasparo, M., and Siragy, H.M. 1999. The AT2 receptor: fact, fancy and fantasy. Regul. Pept. 81:11-24.
9. Horiuchi, M., Hayashida, W., Kambe, T., Yamada, T., and Dzau, V.J. 1997. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem. 272:19022-19026.
10. Yamada, T., Horiuchi, M., and Dzau, V.J. 1996. Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sci. USA. 93:156-160.
11. Munzenmaier, D.H., and Greene, A.S. 1996. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension. 27:760-765.
12. Scheuer, D.A., and Perrone, M.H. 1993. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am. J. Physiol. 264:R917-R923.
13. Siragy, H.M., and Carey, R.M. 1996. The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3′, 5′-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats [see comments]. J. Clin. Invest. 97:1978-1982.
14. Siragy, H.M., and Carey, R.M. 1997. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J. Clin. Invest. 100:264-269.
15. Gohlke, P., Pees, C., and Unger, T. 1998. AT2 receptor stimulation incteases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 31:349-355.
16. Tsutsumi, Y., et al. (1999). Angiotensin II type2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest. 104:925-935
17. Ichiki, T., et al. 1998. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension. 31:342-348.